James S Scibetta Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James S Scibetta.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James S Scibetta. James S Scibetta is President in Pacira Pharmaceuticals, Inc. ($PCRX) and President & CFO in Pacira Pharmaceuticals, Inc. ($PCRX) and SVP, Chief Financial Officer in Pacira Pharmaceuticals, Inc. ($PCRX) and in Aquestive Therapeutics, Inc. ($AQST) and Director in Matinas BioPharma Holdings, Inc. ($MTNB).
Latest Insider Trading Transactions of James S Scibetta
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQST, MTNB, PCRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 4.04 | 20,000 | 80,800 | 20,000 | ||
| Nov 10 2020 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | A | 0.82 | 122,605 | 100,536 | 122,605 | |
| Jun 24 2020 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | J | 0.00 | 3,600 | 0 | 621,158 | 617.6 K to 621.2 K (+0.58 %) |
| Jun 18 2020 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
| Oct 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | J | 0.00 | 2,400 | 0 | 609,298 | 606.9 K to 609.3 K (+0.40 %) |
| Oct 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 29,739 | 0 | 606,898 | 577.2 K to 606.9 K (+5.15 %) |
| Aug 22 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Buy | P | 3.81 | 900 | 3,429 | 31,635 | 30.7 K to 31.6 K (+2.93 %) | |
| Aug 22 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Buy | P | 3.80 | 11,310 | 43,001 | 30,735 | 19.4 K to 30.7 K (+58.22 %) | |
| Aug 22 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Buy | P | 3.77 | 10,761 | 40,547 | 19,425 | 8.7 K to 19.4 K (+124.20 %) | |
| Jul 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 21,879 | 0 | 577,159 | 555.3 K to 577.2 K (+3.94 %) |
| Jun 17 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
| Jun 17 2019 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 4.38 | 13,350 | 58,473 | 13,350 | ||
| Apr 03 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 17,202 | 0 | 555,280 | 538.1 K to 555.3 K (+3.20 %) |
| Jan 04 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 31,513 | 0 | 538,078 | 506.6 K to 538.1 K (+6.22 %) |
| Nov 05 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
| Nov 05 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
| Oct 03 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 20,381 | 0 | 506,565 | 486.2 K to 506.6 K (+4.19 %) |
| Jul 26 2018 | AQST | Aquestive Therapeu ... | Scibetta James S | Option Exercise | A | 15.00 | 26,700 | 400,500 | 26,700 | ||
| Jul 11 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 43,203 | 0 | 486,184 | 443 K to 486.2 K (+9.75 %) |
| Jun 22 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | P | 0.50 | 12 | 6 | 12 | |
| Apr 02 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 24,672 | 0 | 442,981 | 418.3 K to 443 K (+5.90 %) |
| Sep 07 2017 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | P | 1.29 | 5,000 | 6,450 | 418,309 | 413.3 K to 418.3 K (+1.21 %) |
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 43.32 | 1,966 | 85,169 | 25,118 | 27.1 K to 25.1 K (-7.26 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 5.49 | 20,000 | 109,800 | 15,251 | |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 51.20 | 20,000 | 1,024,000 | 27,084 | 47.1 K to 27.1 K (-42.48 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 5.49 | 20,000 | 109,800 | 47,084 | 27.1 K to 47.1 K (+73.84 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 5.49 | 17,627 | 96,772 | 35,251 | |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 2,373 | 3,821 | 0 | |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 38.97 | 4,997 | 194,733 | 27,084 | 32.1 K to 27.1 K (-15.58 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 38.39 | 15,003 | 575,965 | 32,081 | 47.1 K to 32.1 K (-31.86 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 5.49 | 17,627 | 96,772 | 47,084 | 29.5 K to 47.1 K (+59.84 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 2,373 | 3,821 | 29,457 | 27.1 K to 29.5 K (+8.76 %) |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | A | 32.35 | 20,000 | 647,000 | 20,000 | |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 20,000 | 32,200 | 2,373 | |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 36.50 | 20,000 | 730,000 | 27,084 | 47.1 K to 27.1 K (-42.48 %) |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 20,000 | 32,200 | 47,084 | 27.1 K to 47.1 K (+73.84 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 15,877 | 25,562 | 22,373 | |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 9,123 | 14,688 | 0 | |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 45.21 | 25,000 | 1,130,250 | 27,084 | 52.1 K to 27.1 K (-48.00 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 15,877 | 25,562 | 52,084 | 36.2 K to 52.1 K (+43.85 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 9,123 | 14,688 | 36,207 | 27.1 K to 36.2 K (+33.68 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Option Exercise | A | 40.34 | 32,500 | 1,311,050 | 32,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Grant | A | 0.00 | 16,250 | 0 | 26,754 | 10.5 K to 26.8 K (+154.70 %) |
| Nov 05 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Option Exercise | A | 55.34 | 40,000 | 2,213,600 | 40,000 | |
| Sep 14 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | P | 61.37 | 5,000 | 306,850 | 10,504 | 5.5 K to 10.5 K (+90.84 %) |
Page: 1